ursodeoxycholic acid has been researched along with Atherogenesis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chesnokov, E; Ivashkin, V; Kaibullayeva, J; Khamrabaeva, F; Kodzoeva, K; Konysbekova, A; Maevskaya, M; Nadinskaia, M; Nersesov, A; Pirogova, I; Raissova, A; Zueva, E | 1 |
| Chang, G; Chen, S; Guo, Z; Huang, K; Li, Z; Liu, C; Liu, R; Peng, M; Su, Q | 1 |
| Aibara, D; Bustin, M; Chen, B; Gonzalez, FJ; Hu, X; Jiang, C; Liang, X; Sun, L; Wang, P; Wang, X; Wu, Q; Xia, J; Xu, F; Yan, Y; Yun, C; Zeng, G; Zhang, S; Zhu, Y | 1 |
| Bagci, S; Demirci, H; Ozturk, K; Uygun, A | 1 |
| An, SH; Chung, J; Kim, KH; Kwon, K; Lee, SC | 1 |
| An, SH; Chung, J; Kang, SW; Kwon, K | 1 |
| Bode, N; Grebe, A; Kerksiek, A; Latz, E; Lütjohann, D; Nickenig, G; Werner, N; Zimmer, S | 1 |
| Abel, T; Fehér, J | 1 |
| Amaral, JD; Rodrigues, CM; Steer, CJ; Xavier, JM | 1 |
| Oĭnotkinova, OSh | 1 |
2 review(s) available for ursodeoxycholic acid and Atherogenesis
| Article | Year |
|---|---|
[Non-alcoholic fatty liver disease and cardiovascular risk].
Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid | 2008 |
The role of p53 in apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Atherosclerosis; Bile Acids and Salts; Drug Design; Genes, p53; Humans; Ischemia; Models, Biological; Mutation; Neoplasms; Neurodegenerative Diseases; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2010 |
1 trial(s) available for ursodeoxycholic acid and Atherogenesis
| Article | Year |
|---|---|
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
Topics: Atherosclerosis; Carotid Intima-Media Thickness; Female; Humans; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2021 |
7 other study(ies) available for ursodeoxycholic acid and Atherogenesis
| Article | Year |
|---|---|
Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E-Deficient Mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Disease Progression; Down-Regulation; Female; Foam Cells; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Scavenger Receptors, Class A; Ursodeoxycholic Acid | 2021 |
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.
Topics: Animals; Atherosclerosis; Ceramides; Diet, High-Fat; Female; Humans; Intestinal Mucosa; Male; Mice; Mice, Knockout, ApoE; Receptors, Cytoplasmic and Nuclear; Sphingomyelin Phosphodiesterase; Ursodeoxycholic Acid | 2021 |
Effect of ursodeoxycholic acid on atherosclerosis.
Topics: Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Evidence-Based Medicine; Humans; Treatment Outcome; Turkey; Ursodeoxycholic Acid | 2015 |
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
Topics: Animals; Apoptosis; Atherosclerosis; Blood Circulation; Carotid Artery, Common; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Monocytes; Plaque, Atherosclerotic; Regulatory Factor X Transcription Factors; Stress, Mechanical; Transcription Factor CHOP; Transcription Factors; Ursodeoxycholic Acid; X-Box Binding Protein 1 | 2015 |
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endoplasmic Reticulum Stress; Human Umbilical Vein Endothelial Cells; Mice; NF-kappa B; Oxidative Stress; Plaque, Atherosclerotic; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
Topics: Animals; Atherosclerosis; Cholagogues and Choleretics; Cholesterol; Crystallization; Dose-Response Relationship, Drug; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Plaque, Atherosclerotic; Treatment Outcome; Ursodeoxycholic Acid | 2016 |
[Specific features of hypolipidemic therapy in patients with abdominal ischemic disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Cholagogues and Choleretics; Drug Therapy, Combination; Fatty Liver; Female; Heptanoic Acids; Humans; Ischemia; Male; Middle Aged; Pyrroles; Ursodeoxycholic Acid; Young Adult | 2012 |